Proportion of overall use stratified by age over the study period for (A) cyproterone acetate/ethinylestradiol, (B) levonorgestrel/ethinylestradiol and (C) drospirenone/ethinylestradiol. Proportion of overall use stratified by age over the study period for (A) cyproterone acetate/ethinylestradiol, (B) levonorgestrel/ethinylestradiol and (C) drospirenone/ethinylestradiol. Lucía Cea-Soriano et al. J Fam Plann Reprod Health Care 2016;42:247-254 Copyright © by the BMJ Publishing Group Ltd & the Faculty of Sexual & Reproductive Healthcare of the Royal College of Obstetricians & Gynaecologists. All rights reserved.